CH625792A5 - - Google Patents

Download PDF

Info

Publication number
CH625792A5
CH625792A5 CH149777A CH149777A CH625792A5 CH 625792 A5 CH625792 A5 CH 625792A5 CH 149777 A CH149777 A CH 149777A CH 149777 A CH149777 A CH 149777A CH 625792 A5 CH625792 A5 CH 625792A5
Authority
CH
Switzerland
Prior art keywords
salt
formula
urapidil
hypertension
iii
Prior art date
Application number
CH149777A
Other languages
German (de)
English (en)
Inventor
Hermann Dr Amschler
Kurt Dr Klemm
Gerhard Dr Ludwig
Wolfgang Dr Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH625792A5 publication Critical patent/CH625792A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH149777A 1976-02-09 1977-02-08 CH625792A5 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74319A LU74319A1 (el) 1976-02-09 1976-02-09

Publications (1)

Publication Number Publication Date
CH625792A5 true CH625792A5 (el) 1981-10-15

Family

ID=19728151

Family Applications (1)

Application Number Title Priority Date Filing Date
CH149777A CH625792A5 (el) 1976-02-09 1977-02-08

Country Status (20)

Country Link
US (1) US4131678A (el)
JP (2) JPS5296718A (el)
AT (1) AT347478B (el)
BE (1) BE851267A (el)
CA (1) CA1065865A (el)
CH (1) CH625792A5 (el)
DE (1) DE2704935C2 (el)
DK (1) DK52877A (el)
ES (1) ES455721A1 (el)
FI (1) FI61891C (el)
FR (1) FR2340316A1 (el)
GB (1) GB1512771A (el)
IE (1) IE44461B1 (el)
IL (1) IL51400A (el)
IT (1) IT1075919B (el)
LU (1) LU74319A1 (el)
NL (1) NL7701289A (el)
NO (1) NO145440C (el)
SE (1) SE7701441L (el)
YU (1) YU32477A (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0452107A1 (en) * 1990-04-13 1991-10-16 MITSUI TOATSU CHEMICALS, Inc. Pyrimidinedione derivatives and antiarrythmic agents containing same

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58130183U (ja) * 1982-02-26 1983-09-02 株式会社ブレスト工業研究所 空調ダクト等の吊持装置
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
CN100353944C (zh) * 2004-06-24 2007-12-12 杨立新 乌拉地尔大容量注射液、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
BE755015A (fr) * 1969-08-20 1971-02-01 Byk Gulden Lomberg Chem Fab Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS5212560A (en) * 1975-07-21 1977-01-31 Hitachi Ltd Electronic beam probe control device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0452107A1 (en) * 1990-04-13 1991-10-16 MITSUI TOATSU CHEMICALS, Inc. Pyrimidinedione derivatives and antiarrythmic agents containing same

Also Published As

Publication number Publication date
FR2340316A1 (fr) 1977-09-02
BE851267A (fr) 1977-08-09
FR2340316B1 (el) 1980-02-08
DE2704935A1 (de) 1977-08-11
IE44461L (en) 1977-08-09
FI61891C (fi) 1982-10-11
JPS5726618A (en) 1982-02-12
IL51400A (en) 1980-12-31
JPS5296718A (en) 1977-08-13
GB1512771A (en) 1978-06-01
FI61891B (fi) 1982-06-30
LU74319A1 (el) 1977-08-19
US4131678A (en) 1978-12-26
CA1065865A (en) 1979-11-06
ES455721A1 (es) 1978-01-01
AT347478B (de) 1978-12-27
NL7701289A (nl) 1977-08-11
IT1075919B (it) 1985-04-22
YU32477A (en) 1982-06-30
JPS5713544B2 (el) 1982-03-17
DE2704935C2 (de) 1985-01-10
NO145440C (no) 1982-03-24
IE44461B1 (en) 1981-12-02
NO145440B (no) 1981-12-14
NO770411L (no) 1977-08-10
FI770406A (el) 1977-08-10
IL51400A0 (en) 1977-04-29
ATA81777A (de) 1978-05-15
SE7701441L (sv) 1977-08-10
DK52877A (da) 1977-08-10

Similar Documents

Publication Publication Date Title
DE1620127C3 (de) 2-Diäthylamino-6,7-dimethoxy-4(3H> chinazolinon. Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Mittel
DE2721171A1 (de) Neues vincaminsalz, seine herstellung und es enthaltende pharmazeutische zubereitungen
DE2012138C3 (de) N{4-(ß-Pyrazin- 2-carboxyamido-äthyl)benzolsulphonyl] -N' - cycloalkylharnstoffe und diese enthaltende pharmazeutische Präparate
AT391864B (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
CH625792A5 (el)
DE2848263A1 (de) Chinazolinderivate, verfahren zu deren herstellung und antihypertensive arzneimittel, welche diese enthalten
DE1568349A1 (de) Neue Diphenylharnstoffe und Verfahren zu ihrer Herstellung
DE1122541B (de) Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
DE2426267C2 (de) (1,3)-Thiazolo[4,3-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Präparate
DE3011809A1 (de) Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung
CH629780A5 (de) Verfahren zur herstellung von benzolsulfonylharnstoffen.
EP0018360A1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung.
DE2818351A1 (de) Benzoesaeurederivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE2366237C2 (de) 4-[2-(2-Methoxynicotinamido)äthyl]-1-piperidinsulfonamid
DE2815442C2 (el)
DE1670168C3 (de) 2-Benzolsulfonamido-4-methyl-5alkyl-pyrimidine und Verfahren zu ihrer Herstellung
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE1545978A1 (de) N-(4-Pyrimidinyl)-anthranilsaeuren und deren Derivate,sowie Verfahren zur Herstellung derselben
DE2238870A1 (de) Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
DE2166270C3 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE4307181C1 (de) Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE1909272A1 (de) N-[4-(ss<2-Methoxy-5-chlor-benzamido>-aethyl)-benzolsulfonyl]-N'-cyclopentylharnstoff und Verfahren zu seiner Herstellung
DE1470421A1 (de) Mehrbasische Verbindungen
EP0061654B1 (de) Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE2511576A1 (de) Metformin-clofibrat, verfahren zu seiner herstellung und es enthaltendes arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased